• Retinoic Acid Overcomes Cisplatin-Induced PARP Inhibitor Res

  2026-04-29

  This study demonstrates that all-trans retinoic acid (ATRA) can resensitize epithelial ovarian cancer (EOC) cells to PARP inhibition after resistance is induced by cisplatin. The findings highlight a promising combination approach to address PARP inhibitor resistance, a major challenge in EOC treatment, and provide mechanistic insight relevant to maintenance therapy strategies.

• Novobiocin Sodium: New Horizons in Anti-Parasitic and DNA Da

  2026-04-29

  Explore how Novobiocin Sodium, a leading aminocoumarin antibiotic, is redefining anti-parasitic and DNA damage studies. This article provides an in-depth, evidence-based perspective beyond bacterial assays, highlighting novel research applications and practical assay guidance.

• Atorvastatin in Ferroptosis and Vascular Biology: Mechanisti

  2026-04-28

  Explore how Atorvastatin, a leading HMG-CoA reductase inhibitor, advances both cholesterol metabolism research and ferroptosis-driven cancer therapy. This article uniquely connects molecular mechanisms with assay design to inform next-generation cardiovascular and oncology studies.

• Indazole/Indole Glucagon Receptor Antagonists: New SAR and S

  2026-04-28

  This study reports the discovery and structure–activity relationships (SAR) of a novel series of indazole- and indole-based glucagon receptor antagonists. The research provides new synthetic routes and demonstrates potent in vitro and in vivo efficacy, with implications for type 2 diabetes therapy and advanced amide bond formation strategies.

• AG-490 (Tyrphostin B42): JAK2/EGFR Inhibition in Cancer Mode

  2026-04-27

  AG-490 (Tyrphostin B42) is a potent JAK2 and EGFR inhibitor used for dissecting signal transduction pathways in cancer and immunopathology. Its activity profile enables robust suppression of JAK-STAT and MAPK signaling. This article details its mechanisms, benchmarks, and practical application limits.

• Urolithin A: Advancing Mitochondrial Quality in Fibrosis Res

  2026-04-27

  This thought-leadership article explores how Urolithin A (3,8-dihydroxy-6H-benzo[c]chromen-6-one) transforms mitochondrial biogenesis research, with a particular focus on its mechanistic synergy with glutamine metabolism and translational applications in liver fibrosis. Integrating the latest findings on hepatic stellate cell metabolism and mitochondrial quality control, the article provides strategic guidance, protocol parameters, and a forward-looking perspective for translational researchers.

• Afatinib (BIBW 2992): Precision Inhibition in Assembloid Mod

  2026-04-26

  Afatinib (BIBW 2992) empowers researchers to dissect drug resistance and optimize targeted therapy in physiologically relevant gastric cancer assembloid systems. This guide translates the latest assembloid modeling advances into practical, stepwise workflows—covering protocol specifics, troubleshooting, and the unique advantages of APExBIO’s high-purity Afatinib for robust, reproducible results.

• MK-1775: Workflow Enhancements for Cell Cycle Checkpoint Abr

  2026-04-25

  MK-1775 (Wee1 kinase inhibitor) from APExBIO enables sensitive, reproducible disruption of the G2 DNA damage checkpoint in p53-deficient tumor models. This article delivers stepwise protocol upgrades, troubleshooting strategies, and actionable guidance for DNA damage response research leveraging best-in-class selectivity and workflow compatibility.

• Amiloride (MK-870): Translational Strategies in Ion Transpor

  2026-04-24

  This thought-leadership article explores the mechanistic and translational landscape of Amiloride (MK-870), emphasizing its dual action as an epithelial sodium channel and uPAR inhibitor. Going beyond standard product pages, it synthesizes recent advances, experimental workflow guidance, and strategic recommendations for researchers navigating the interface of ion transport, endocytosis, and disease modeling.

• Biodentine Rejuvenates Aged Dental Pulp Stem Cells via Wnt/β

  2026-04-24

  This study demonstrates that Biodentine significantly promotes proliferation and counteracts senescence in human dental pulp stem cells (hDPSCs), particularly those derived from older individuals, by activating the Wnt/β-catenin signaling pathway. These findings highlight a mechanistic basis for Biodentine’s regenerative potential in vital pulp therapy and suggest new strategies for overcoming age-related limitations in dental tissue engineering.

• S63845 MCL1 Inhibitor: Precision Control of Cancer Cell Apop

  2026-04-23

  Explore how S63845, a potent MCL1 inhibitor, enables mechanistic dissection and strategic modulation of mitochondrial apoptosis in cancer research. This article uniquely integrates breakthrough findings on apoptosis network targeting and practical assay implications for hematological and solid tumors.

• MOG (35-55) Peptide: Mechanistic Advances in Translational M

  2026-04-23

  This article explores how the MOG (35-55) myelin oligodendrocyte glycoprotein peptide empowers experimental autoimmune encephalomyelitis (EAE) modeling, integrating recent molecular insights such as PARP7-STAT1/2 regulation. Designed for translational researchers, it provides mechanistic context, protocol clarity, and strategic guidance for optimizing autoimmune disease models and neuroinflammation assays, referencing both seminal literature and workflow-driven best practices.

• Indazole/Indole Glucagon Receptor Antagonists: Synthesis and

  2026-04-22

  This article examines the development of a novel series of indazole- and indole-based glucagon receptor antagonists for type 2 diabetes mellitus (T2DM), as reported by Lin et al. The study introduces key advances in synthetic methodology, including strategic amide bond formation and structure–activity relationship (SAR) optimization, with implications for drug discovery targeting hepatic glucose regulation.

• KN-62: Deconstructing Calcium Signaling and Memory Maintenan

  2026-04-22

  Explore how KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine, enables precise dissection of calcium signaling in memory maintenance. This article uniquely bridges molecular inhibition with emerging neurobiological insights, offering actionable protocols and deep comparative analysis.

• Medroxyprogesterone acetate: Scenario-Based Solutions for Re

  2026-04-21

  This article applies a scenario-driven approach to real laboratory challenges in cell viability, hormone signaling, and endometrial research. Focusing on Medroxyprogesterone acetate (SKU B1510), we detail evidence-backed protocols, highlight workflow optimizations, and compare vendor reliability for researchers seeking reproducible results in biomedical assays.

16571 records 1/1105 page Next 12345 下5页 Last page